Back
Inhibrx Biosciences Vs. IGC Pharma Industry Stock Comparison
Sell
20
INBX
Inhibrx Biosciences
Last Price:
$14.43
Seasonality Move:
--
Sell
32
IGC
IGC Pharma
Last Price:
$0.36
Seasonality Move:
16.78%
Sell
20
Inhibrx Biosciences (INBX)
is a Sell
Is Inhibrx Biosciences a Buy, Sell or Hold?
-
The current Inhibrx Biosciences [INBX] share price is $14.53. The Score for INBX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
INBX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
32
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
-
The current IGC Pharma [IGC] share price is $0.38. The Score for IGC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INBX Stock Price Chart
What is Inhibrx Biosciences's stock price today?
-
The Inhibrx Biosciences share price today is $14.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
INBX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 46.12 | Sell |
Chaikin Money Flow: | 185645 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.11 - 15.25) | Sell |
Bollinger Bands (100): | (13.45 - 16.25) | Sell |
IGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 728323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.39) | Buy |
Bollinger Bands (100): | (0.35 - 0.41) | Sell |
INBX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.52 | Buy |
20-day SMA: | 14.86 | Sell |
50-day SMA: | 15.24 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 14.48 | Buy |
20-day EMA: | 14.75 | Sell |
50-day EMA: | 15 | Sell |
200-day EMA: | 4.53 | Buy |
IGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.38 | Sell |
20-day SMA: | 0.37 | Buy |
50-day SMA: | 0.38 | Buy |
200-day SMA: | 0.42 | Sell |
8-day EMA: | 0.37 | Buy |
20-day EMA: | 0.37 | Buy |
50-day EMA: | 0.37 | Buy |
200-day EMA: | 0.39 | Sell |
Inhibrx Biosciences Earnings Growth & INBX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.11 per share.
Inhibrx Biosciences Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IGC Pharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |